Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China
· Delayed Price · Currency is CNY 15.54
-0.16 (-1.02%)
Mar 11, 2026, 1:15 PM CST
SHE:300452 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 10, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,652 | 2,817 | 3,308 | 4,071 | 3,916 | 3,094 | Upgrade
|
| Market Cap Growth | 30.08% | -14.85% | -18.74% | 3.96% | 26.59% | 46.83% | Upgrade
|
| Enterprise Value | 3,306 | 2,573 | 3,058 | 3,852 | 3,747 | 2,995 | Upgrade
|
| Last Close Price | 15.70 | 11.81 | 13.62 | 16.52 | 15.61 | 12.15 | Upgrade
|
| PE Ratio | 28.88 | 23.59 | 20.48 | 31.15 | 43.88 | 32.93 | Upgrade
|
| Forward PE | - | 62.00 | 62.00 | 62.00 | 62.00 | 62.00 | Upgrade
|
| PS Ratio | 3.91 | 3.19 | 3.94 | 5.78 | 6.35 | 5.82 | Upgrade
|
| PB Ratio | 3.53 | 2.89 | 3.54 | 5.16 | 5.55 | 4.72 | Upgrade
|
| P/TBV Ratio | 4.02 | 3.30 | 4.27 | 6.47 | 7.17 | 6.14 | Upgrade
|
| P/FCF Ratio | 23.13 | 31.17 | 42.76 | 62.16 | 54.13 | 48.19 | Upgrade
|
| P/OCF Ratio | 18.57 | 23.81 | 25.01 | 30.65 | 37.72 | 36.16 | Upgrade
|
| EV/Sales Ratio | 3.54 | 2.92 | 3.64 | 5.47 | 6.08 | 5.64 | Upgrade
|
| EV/EBITDA Ratio | 14.00 | 11.64 | 15.28 | 24.52 | 29.33 | 23.17 | Upgrade
|
| EV/EBIT Ratio | 18.74 | 15.10 | 18.96 | 31.83 | 40.26 | 30.71 | Upgrade
|
| EV/FCF Ratio | 20.93 | 28.46 | 39.53 | 58.80 | 51.79 | 46.65 | Upgrade
|
| Debt / Equity Ratio | 0.30 | 0.31 | 0.32 | 0.05 | 0.04 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 1.32 | 1.38 | 1.49 | 0.25 | 0.24 | 0.31 | Upgrade
|
| Debt / FCF Ratio | 1.97 | 3.37 | 3.85 | 0.61 | 0.43 | 0.62 | Upgrade
|
| Net Debt / Equity Ratio | -0.40 | -0.41 | -0.41 | -0.41 | -0.42 | -0.40 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.77 | -1.82 | -1.94 | -2.07 | -2.33 | -2.01 | Upgrade
|
| Net Debt / FCF Ratio | -2.64 | -4.46 | -5.02 | -4.96 | -4.12 | -4.06 | Upgrade
|
| Asset Turnover | 0.59 | 0.57 | 0.62 | 0.66 | 0.66 | 0.62 | Upgrade
|
| Inventory Turnover | 7.16 | 6.67 | 6.20 | 5.86 | 6.93 | 7.69 | Upgrade
|
| Quick Ratio | 4.15 | 3.92 | 3.04 | 1.42 | 2.06 | 1.95 | Upgrade
|
| Current Ratio | 4.58 | 4.38 | 3.44 | 1.83 | 2.48 | 2.26 | Upgrade
|
| Return on Equity (ROE) | 12.89% | 12.62% | 19.10% | 17.52% | 12.57% | 14.94% | Upgrade
|
| Return on Assets (ROA) | 6.93% | 6.87% | 7.41% | 7.06% | 6.24% | 7.12% | Upgrade
|
| Return on Invested Capital (ROIC) | 24.66% | 25.79% | 28.28% | 26.65% | 20.52% | 21.88% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.70% | 12.90% | 12.70% | 14.50% | 12.60% | 14.30% | Upgrade
|
| Earnings Yield | 3.55% | 4.24% | 4.88% | 3.21% | 2.28% | 3.04% | Upgrade
|
| FCF Yield | 4.32% | 3.21% | 2.34% | 1.61% | 1.85% | 2.08% | Upgrade
|
| Dividend Yield | 1.95% | 2.54% | 1.84% | 1.51% | 1.48% | 1.58% | Upgrade
|
| Payout Ratio | 55.19% | 49.41% | 37.01% | 42.33% | 51.90% | 37.34% | Upgrade
|
| Buyback Yield / Dilution | 1.85% | 2.88% | -3.29% | 0.63% | -1.93% | 1.27% | Upgrade
|
| Total Shareholder Return | 3.81% | 5.42% | -1.46% | 2.14% | -0.46% | 2.85% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.